Immunomodulatory effects of curcumin: In-vivo

International Immunopharmacology

Volumn 8, Issue 5, 2008, Pages 688-700

  Varalakshmi, Ch ^a   Ali, A Mubarak ^a   Pardhasaradhi, B V V ^a   Srivastava, Raghvendra M ^a   Singh, Sarvjeet ^a   Khar, Ashok ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Curcumin; Lymphoproliferation; Macrophages; NK cells; NO; ROS

Indexed keywords

ANTIGEN; CD3 ANTIBODY; CURCUMIN; CYCLOSPORIN A; CYTOKINE; IMMUNOMODULATING AGENT; MITOGENIC AGENT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; EFFECTOR CELL; EMBRYO; FEMALE; IMMUNE SYSTEM; IN VIVO STUDY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TUMOR;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL PROLIFERATION; CURCUMIN; CYCLOSPORINE; FEMALE; IMMUNOLOGIC FACTORS; INDICATORS AND REAGENTS; KILLER CELLS, NATURAL; MACROPHAGES; NITRIC OXIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES;

EID: 41149158492     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.008     Document Type: Article

References (58)

1. Aggarwal B.B., Sundaram C., Malani N., and Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 595 (2007) 1-75
2. Payton F., Sandusky P., and Alworth W.L. NMR study of the solution structure of curcumin. J Nat Products 70 (2007) 143-146
3. Ingolfsson H.I., Ii R.E., and Andersen O.S. Curcumin is a modulator of bilayer material properties. Biochemistry 46 (2007) 10384-10391
4. Jaruga E., Sokal A., Chrul S., and Bartosz G. Apoptosis-independent alterations in membrane dynamics induced by curcumin. Exp Cell Res 245 (1998) 303-312
5. Aggarwal B.B., and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71 (2006) 1397-13421
6. Lin J.K. Molecular targets of curcumin. Adv Exp Med Biol 595 (2007) 227-243
7. Singh S., and Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270 (1995) 24995-25000
8. Khar A., Ali A.M., Pardhasaradhi B.V., Varalakshmi C.H., Anjum R., and Kumari A.L. Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 6 (2001) 368-376
9. Thangapazham R.L., Sharma A., and Maheshwari R.K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8 (2006) E443-E449
10. Churchill M., Chadburn A., Bilinski R.T., and Bertagnolli M.M. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89 (2000) 169-175
11. Chan W.H., Wu H.Y., and Chang W.H. Dosage effects of curcumin on cell death types in a human osteoblast cell line. Food Chem Toxicol 44 (2006) 1362-1371
12. Limtrakul P. Curcumin as chemosensitizer. Adv Exp Med Biol 595 (2007) 269-300
13. Khar A., Ali A.M., Pardhasaradhi B.V., Begum Z., and Anjum R. Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett 445 (1999) 165-168
14. Bhaumik S., Jyothi M.D., and Khar A. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483 (2000) 78-82
15. Syng-Ai C., Kumari A.L., and Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther (2004) 1101-1108
16. Natarajan C., and Bright J.J. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168 (2002) 6506-6513
17. Zhang L., Fiala M., Cashman J., Sayre J., Espinosa A., Mahanian M., et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimer's Dis 10 (2006) 1-7
18. Chen H.W., Kuo H.T., Chai C.Y., Ou J.L., and Yang R.C. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia. J Endotoxin Res 13 (2007) 15-23
19. Gradisar H., Keber M.M., Pristovsek P., and Jerala R. MD-2 as the target of curcumin in the inhibition of response to LPS. J Leukoc Biol 82 (2007) 968-974
20. Youn H.S., Saitoh S.I., Miyake K., and Hwang D.H. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72 (2006) 62-69
21. Cho J.W., Lee K.S., and Kim C.W. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19 (2007) 469-474
22. Funk J.L., Oyarzo J.N., Frye J.B., Chen G., Lantz R.C., Jolad S.D., et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Products 69 (2006) 351-355
23. Park C., Moon D.O., Choi I.W., Choi B.T., Nam T.J., Rhu C.H., et al. Curcumin induces apoptosis and inhibits prostaglandin E2 production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 20 (2007) 365-372
24. Kurup V.P., Barrios C.S., Raju R., Johnson B.D., Levy M.B., and Fink J.N. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy 5 (2007) 1
25. Pan M.H., Huang T.M., and Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug metab dispos 27 (1999) 486-494
26. Mishra S., Kapoor N., Mubarak Ali A., Pardhasaradhi B.V., Kumari A.L., Khar A., et al. Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Rad Biol Med 38 (2005) 1353-1360
27. Pick E. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol 132 (1986) 407-421
28. Brouet I., and Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206 (1995) 533-540
29. Okazaki Y., Iqbal M., and Okada S. Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 1740 (2005) 357-366
30. Jagetia G.C., and Aggarwal B.B. "Spicing up" of the immune system by curcumin. J Clin Immunol 27 (2007) 19-35
31. Gao X., Kuo J., Jiang H., Deeb D., Liu Y., Divine G., et al. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68 (2004) 51-61
32. Yadav V.S., Mishra K.P., Singh D.P., Mehrotra S., and Singh V.K. Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27 (2005) 485-497
33. Bhattacharyya S., Mandal D., Saha B., Sen G.S., Das T., and Sa G. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem 282 (2007) 15954-15964
34. Ranjan D., Johnston T.D., Wu G., Elliott L., Bondada S., and Nagabhushan M. Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J Surg Res 7 (1998) 174-178
35. Deters M., Klabunde T., Meyer H., Resch K., and Kaever V. Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat. Planta Med 69 (2003) 337-343
36. Yasni S., Yoshiie K., Oda H., Sugano M., and Imaizumi K. Dietary Curcuma xanthorrhiza Roxb. increases mitogenic responses of splenic lymphocytes in rats, and alters populations of the lymphocytes in mice. J Nutr Sci Vitaminol 39 (1993) 345-354
37. Kim S.J., and Hellerstein M.K. Pharmacological doses of dietary curcumin increase colon epithelial cell proliferation in vivo in rats. Phytother Res. 21 (2007) 995-998
38. + ATPases in concanavalin A-stimulated human blood mononuclear cells. International J Mol Sci. 4 (2003) 34-44
39. Zhang W., Tan T.M., and Lim L.Y. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispo.: The biological fate of chemicals 35 (2007) 110-115
40. Chearwae W., Anuchapreeda S., Nandigama K., Ambudkar S.V., and Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol 68 (2004) 2043-2052
41. Anuchapreeda S., Leechanachai P., Smith M.M., Ambudkar S.V., and Limtrakul P.N. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64 (2002) 573-582
42. Forman H.J., and Torres M. Redox signaling in macrophages. Mol Aspects Med 22 (2001) 189-216
43. Chan W.H., Wu C.C., and Yu J.S. Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem 90 (2003) 327-338
44. Bhaumik S., Anjum R., Rangaraj N., Pardhasaradhi B.V., and Khar A. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456 (1999) 311-314
45. Kang J., Chen J., Shi Y., Jia J., and Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem pharmacol. 69 (2005) 1205-1213
46. Chander V., and Chopra K. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide. Toxicology 207 (2005) 463-474
47. Chander V., Tirkey N., and Chopra K. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 210 (2005) 55-64
48. Kim S.H., Kim J., and Sharma R.P. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res 49 (2004) 433-439
49. Bogdan C. Nitric oxide and the immune response. Nature Immunol 2 (2001) 907-916
50. Farias-Eisner R., Sherman M.P., Aeberhard E., and Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci USA 91 (1994) 9407-9411
51. Mitra R., Bhaumik S., and Khar A. Differential modulation of host macrophage function by AK-5 tumor is dependent on the site of tumor transplantation. Immunol Lett 82 (2002) 183-190
52. Bhaumik S., Mitra R., Varalakshmi C., and Khar A. Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking. Exp Cell Res 266 (2001) 44-52
53. Mitra R., and Khar A. Role of reactive nitrogen intermediates and protein nitration during immune response against a rat histiocytoma. Immunol Lett 84 (2002) 145-151
54. Hortelano S., Lopez-Collazo E., and Bosca L. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages. Br J Pharmacol 126 (1999) 1139-1146
55. Khar A., Pardhasaradhi B.V., Varalakshmi C., Ali A.M., and Kumari A.L. Natural killer cell as the effector which mediates in vivo apoptosis in AK-5 tumor cells. Cell Immunol 177 (1997) 86-92
56. Das S., and Khar A. Regulation of NK cell function in vivo by the dose of tumour transplanted in the peritoneum. Immunol Lett 83 (2002) 133-142
57. Zhang H.G., Kim H., Liu C., Yu S., Wang J., Grizzle W.E., et al. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta 1773 (2007) 1116-1123
58. Kang B.Y., Song Y.J., Kim K.M., Choe Y.K., Hwang S.Y., and Kim T.S. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmcol 128 (1999) 380-384